Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Marcello Maggio is active.

Publication


Featured researches published by Marcello Maggio.


Journal of the American Geriatrics Society | 2006

Association Between Hormones and Metabolic Syndrome in Older Italian Men

Marcello Maggio; Fulvio Lauretani; Gian Paolo Ceda; Stefania Bandinelli; Shehzad Basaria; Alessandro Ble; Josephine Egan; Giuseppe Paolisso; Samer S. Najjar; E. Jeffrey Metter; Giorgio Valenti; Jack M. Guralnik; Luigi Ferrucci

OBJECTIVES: To determine whether low levels of testosterone, sex hormone binding globulin (SHBG), insulin‐like growth factor‐1 (IGF‐1), and dehydroepiandrosterone sulfate (DHEAS) and high levels of cortisol and leptin would be associated with metabolic syndrome (MS).


International Journal of Impotence Research | 2009

Welcoming low testosterone as a cardiovascular risk factor

Marcello Maggio; Shehzad Basaria

Male hypogonadism now has a new spectrum of complications. They are mainly cardiometabolic in nature. Low serum testosterone levels are a risk factor for diabetes, metabolic syndrome, inflammation and dyslipidemia. These metabolic and inflammatory complications are not without consequences. Recent studies have shown low serum testosterone levels to be an independent risk factor of cardiovascular and all-cause mortality. It is time to welcome low serum testosterone levels as a cardiovascular risk factor.


Journal of Endocrinological Investigation | 2005

Acute changes in circulating hormones in older patients with impaired ventricular function undergoing on-pump coronary artery bypass grafting.

Marcello Maggio; G. P. Ceda; G. De Cicco; E. Cattadori; S. Visioli; Fabrizio Ablondi; Cesare Beghi; Tiziano Gherli; Shehzad Basaria; Graziano Ceresini; Giorgio Valenti; Luigi Ferrucci

Objectives: Coronary artery bypass grafting (CABG) with cardiopulmonary bypass (CPB) causes an acute stress response characterized by changes in the levels of several hormones, which might play a role in the high complication rate experienced by older patients after CABG. Thus, the aim of the study was to investigate changes in the circulating levels of anabolic and catabolic hormones in old people undergoing CABG with CPB. Design: Intervention case study. Methods: 19 patients (12 males, 7 females) aged 70.1 ± 6.1 yr (age range 62–80) with coronary artery disease and an ejection fraction <40% who underwent cardiac surgery. Cortisol (Cort), DHEA, DHEAS, LH, estradiol (E2), total testosterone (Te), SHBG, IGF-I were measured the day before, on the day of the procedure and 1, 2, 3, 4, and 30 days after CABG. Results: After surgery, serum IGF-I levels decreased (p<0.001), while levels of Cort, DHEAS and E2 significantly increased in both men and women. Alterations in Te levels differed between the two sexes with a significant decline in men and a significant increment in women. Conclusion: CABG with CPB resulted in a dramatic drop in Te levels in old men and a significant decline in IGF-I in both sexes. Serum Cort levels also significantly increased in both sexes. These hormonal changes may, at least partially, explain why the elderly need prolonged rehabilitation after CABG.


Journal of Andrology | 2010

Estradiol and Metabolic Syndrome in Older Italian Men: The InCHIANTI Study

Marcello Maggio; Fulvio Lauretani; Gian Paolo Ceda; Stefania Bandinelli; Shehzad Basaria; Giuseppe Paolisso; Claudio Giumelli; Michele Luci; Samer S. Najjar; E. Jeffrey Metter; Giorgio Valenti; Jack M. Guralnik; Luigi Ferrucci

The increasing prevalence of metabolic syndrome (MS) with age in older men has been linked with decreasing testosterone levels. Interestingly, while testosterone levels decline with age, estradiol (E2) levels remain relatively stable, resulting in a decreased testosterone:E2 ratio. Because E2 levels tend to be elevated in morbid obesity, insulin resistance, and diabetes, it is reasonable to hypothesize that high E2 levels are associated with MS in older men. We studied the relationship of total and free E2 with MS after adjustment for multiple confounders, including age, BMI, smoking, alcohol consumption, physical activity, interleukin-6 (IL-6), fasting insulin, and testosterone. Men 65 years or older (age range, 65-96; n = 452) had complete data on E2, testosterone, fasting insulin, sex hormone-binding globulin, IL-6, and albumin. Concentrations of free E2 and free testosterone were calculated using the mass action equations. MS was defined according to Adult Treatment Panel III (ATP-III). Participants with MS had significantly higher serum free and total E2 (P < .001) (P = .003). After adjusting for confounders, including age, smoking, alcohol consumption, physical activity, log(IL-6), and log(insulin), participants with higher log(total E2) (odds ratio [OR], 2.31; 95% confidence interval [95% CI], 1.39-4.70; P = .02) and higher log(free E2) (OR, 2.69; 1.38-5.24; P < .001) had an increased risk of having MS. Log(free E2) (P = .04) maintained significant correlation with MS, even after further adjustment for BMI. In older men, high E2 is independently associated with MS. Whether confirmed in other studies, assessment of E2 should be also considered in older men. Whether changes in this hormonal pattern play a role in the development of MS should be further tested in longitudinal studies.


Journal of the American Geriatrics Society | 2009

Relationship Between Higher Estradiol Levels and 9-Year Mortality in Older Women: The Invecchiare in Chianti Study

Marcello Maggio; Gian Paolo Ceda; Fulvio Lauretani; Stefania Bandinelli; Carmelinda Ruggiero; Jack M. Guralnik; E. Jeffrey Metter; Shari M. Ling; Giuseppe Paolisso; Giorgio Valenti; Anne R. Cappola; Luigi Ferrucci

OBJECTIVES: To investigate the relationship between total estradiol (E2) levels and 9‐year mortality in older postmenopausal women not taking hormone replacement therapy (HRT).


European Journal of Clinical Pharmacology | 2007

Use of ACE inhibitors is associated with elevated levels of IGFBP-3 among hypertensive older adults: results from the IlSIRENTE study

Graziano Onder; Rosa Liperoti; Andrea Russo; Ettore Capoluongo; Angelo Minucci; Paola Lulli; Matteo Cesari; Marcello Maggio; Roberto Bernabei; Francesco Landi

ObjectiveSeveral studies in vitro or in rodent models have suggested a potential relationship between angiotensin-converting enzyme (ACE) inhibition and the insulin-like growth factor 1 (IGF-1) axis. However, this relationship has only rarely been investigated in humans. The aim of the present cross-sectional study was to assess the association of ACE inhibitors with free IGF-1 and IGFBP-3 in the blood of older hypertensive adults.MethodsData are from the baseline evaluation of the ilSIRENTE study, which enrolled 364 subjects aged 80 or older. For the present study we selected a subpopulation of 264 hypertensive participants without congestive heart failure. Free IGF-1 and IGFBP-3 in the blood were measured by a radioimmunoassay method. Analyses of covariance were performed to evaluate the differences in free IGF-1 and IGFBP-3 levels according to the use of ACE inhibitors.ResultsThe mean age of participants was 85.7xa0years (SD: 4.9), 170 (64%) were women and 123 (47%) were using an ACE inhibitor. Following adjustment for potential confounders, the concentration of free IGF-1 was slightly, but not significantly higher among ACE inhibitor users than among non-users (0.74 vs. 0.65xa0ng/mL; pu2009=u20090.20). In contrast, ACE inhibitor users had a significantly higher IGFBP-3 serum levels than non-users (4821 vs. 4330xa0ng/mL; pu2009=u20090.005). In addition, the concentration of IGFBP-3 was significantly higher among ACE inhibitors users than among non-users of antihypertensive drugs (pu2009=u20090.02) and users of other antihypertensive drugs (pu2009=u20090.01).ConclusionAmong hypertensive older adults, ACE inhibitors use is associated with higher IGFBP-3 levels.


Journal of the American Geriatrics Society | 2007

The Interplay Between Uric Acid and Antioxidants in Relation to Physical Function in Older Persons

Carmelinda Ruggiero; Antonio Cherubini; Jack M. Guralnik; Richard D. Semba; Marcello Maggio; Shari M. Ling; Fulvio Lauretani; Stefania Bandinelli; Umberto Senin; Luigi Ferrucci

OBJECTIVES: To investigate the relationship between circulating uric acid (UA) levels and plasma antioxidants and whether antioxidant levels modulate the association between UA and physical function.


Journals of Gerontology Series A-biological Sciences and Medical Sciences | 2006

Interleukin-6 in Aging and Chronic Disease: A Magnificent Pathway

Marcello Maggio; Jack M. Guralnik; Dan L. Longo; Luigi Ferrucci


European Heart Journal | 2006

Uric acid and inflammatory markers

Carmelinda Ruggiero; Antonio Cherubini; Alessandro Ble; Angelo Bos; Marcello Maggio; Vishwa D. Dixit; Fulvio Lauretani; Stefania Bandinelli; Umberto Senin; Luigi Ferrucci


The Journal of Clinical Endocrinology and Metabolism | 2007

Aging, Androgens, and the Metabolic Syndrome in a Longitudinal Study of Aging

Annabelle Rodriguez; Denis C. Muller; E. Jeffrey Metter; Marcello Maggio; S. Mitchell Harman; Marc R. Blackman; Reubin Andres

Collaboration


Dive into the Marcello Maggio's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Shehzad Basaria

Brigham and Women's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

E. Jeffrey Metter

University of Tennessee Health Science Center

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge